Skip to content
Smruthi Organics logo

Smruthi Organics

540686 BSE
₹144.95 up 8.95 (6.58%)
Market Cap
₹166 Cr
P/E
22.40

Smruthi Organics (SMRUTHIORG) share price was ₹136.00 at the 28 Oct 2026 close; market capitalisation ₹156 Cr; P/E (TTM) 21.02; sector Healthcare. The share price rose 5.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 55.4% year on year to ₹29.30 Cr and net profit was ₹2.88 Cr, against −₹1.10 Cr a year earlier (compared with Jun 2025). Promoters held 64.73% of Smruthi Organics in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 62/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹136.00 +5.20 +3.98% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹166 Cr
P/E (TTM)
22.4
EBITDA
₹13.20 Cr
Return on Equity
4.66%
Debt to Equity
0.11
Book Value
₹64.22
EPS (TTM)
₹6.47
52W High
₹175.30
52W Low
₹95.00

Price-based figures as of 29 Oct 2026, 10:42 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,764.0034.994,23,243 Cr5.060.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,667.5087.742,56,642 Cr15.310.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,590.6072.071,74,612 Cr9.500.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,194.10108.401,18,550 Cr22.370.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,183.9026.341,18,094 Cr4.360.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.7032.721,10,329 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Smruthi Organics (this company)
₹144.9522.40166 Cr2.261.10%4.66%8.25%112 Cr7 Cr
Median 8 companies₹1,564.8534.831,18,322 Cr4.710.72%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

62 Good
Overall score

Data confidence 100/100

Category scores

Quality Strong 76
Returns, margins, earnings quality 22% weight
Valuation Good 65
Cheap vs sector & own history 24% weight
Growth Poor 30
Sales & profit trajectory 9% weight
Financial Health Strong 67
Solvency, leverage, coverage 9% weight
Momentum Strong 78
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 48.7%
  • Debtor days have improved from 93.5 to 69.1 days.

Weaknesses

2
  • The company has delivered a poor sales growth of -4.22% over past five years.
  • Company has a low return on equity of 5.14% over last 3 years.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
9
Neutral
5
Bullish
5

Moving Averages

Bearish

Bearish
7
Neutral
0
Bullish
3

Growth Rate

Revenue Growth
-19.03% lower than 3Y

change over 1 year

Net Income Growth
-5.56% lower than 3Y

change over 1 year

Cash Flow Change
123%

change over 1 year

EBITDA Margin Change
32.48%

change over 1 year Operating margin 19.83% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
34.91
29.59
23.48
39.66
27.27
29.39
31.25
38.09
18.85
31.6
22.29
29.05
29.3
Expenses
30.29
25.16
24.66
35.58
26.82
26.5
27.08
33.41
18.56
26.59
18.29
25.15
23.49
Operating Profit
4.62
4.43
-1.18
4.08
0.45
2.89
4.17
4.68
0.29
5.01
4
3.9
5.81
OPM %
13.23%
14.97%
-5.03%
10.29%
1.65%
9.83%
13.34%
12.29%
1.54%
15.85%
17.95%
13.43%
19.83%
Other Income
0.01
0
0
0.06
0
0.01
0
0.08
0.04
0.01
-0.44
-0.07
-0.04
Interest
0.33
0.39
0.32
0.37
0.41
0.44
0.51
0.52
0.46
0.66
0.25
0.31
0.31
Depreciation
1.24
1.38
1.45
1.59
1.29
1.33
1.37
1.5
1.41
1.51
1.67
1.75
1.6
PBT
3.06
2.66
-2.95
2.18
-1.25
1.13
2.29
2.74
-1.54
2.85
1.64
1.77
3.86
Tax %
25.49%
22.56%
-22.03%
30.73%
-26.4%
31.86%
35.37%
18.61%
-28.57%
27.72%
14.63%
39.55%
25.65%
Net Profit
2.29
2.07
-2.29
1.52
-0.92
0.78
1.48
2.23
-1.1
2.06
1.4
1.07
2.88
EPS (₹)
2
1.81
-2
1.33
-0.8
0.68
1.29
1.95
-0.96
1.8
1.22
0.93
2.52
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
77
74
79
97
137
131
126
133
141
128
126
102
112
Expenses
72
63
69
94
121
116
98
115
131
116
114
89
94
Operating Profit
5
11
10
3
17
15
29
18
10
12
12
13
19
OPM %
6%
14%
13%
3.4%
12%
12%
23%
14%
7%
9%
10%
13%
17%
Other Income
0
0
1
0
1
4
1
1
0
0
0
0
-1
Interest
6
5
4
4
4
3
1
1
1
1
2
2
2
Depreciation
5
4
4
4
4
4
4
4
5
6
6
6
7
PBT
-6
2
3
-5
10
12
24
14
4
5
5
5
10
Tax %
-33%
55%
39%
-31%
30%
30%
29%
25%
8%
28%
27%
27%
—
Net Profit
-4
1
2
-3
7
8
17
10
4
4
4
3
7
EPS (₹)
-3.34
0.63
1.39
-2.82
6.02
7.41
14.95
9.07
3.61
3.14
3.11
3
6.47
Div. Payout %
0%
0%
0%
0%
11%
14%
20%
33%
55%
48%
48%
50%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
4
4
4
4
4
11
11
11
11
11
11
Reserves
26
27
28
25
33
39
49
56
57
58
60
62
Borrowings
45
37
33
31
28
16
10
3
6
12
17
8
Other Liabilities
34
35
20
25
37
30
21
18
32
37
23
22
Total Liabilities
109
103
85
85
101
88
92
88
106
118
112
104
Fixed Assets
35
32
30
30
30
32
31
33
37
40
45
47
CWIP
1
1
1
1
2
0
1
1
2
1
3
3
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
72
69
54
54
69
56
60
53
66
77
64
54
Total Assets
109
103
85
85
101
88
92
88
106
118
112
104
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9
14
9
5
12
21
23
2
12
4
10
22
Investing
-1
0
0
-3
-4
-5
-3
7
-10
-7
-11
-9
Financing
-8
-14
-9
-2
-5
-17
-7
-12
-2
3
1
-12
Net Cash Flow
-1
0
0
0
2
-1
13
-3
0
0
0
1
Free Cash Flow
7
13
8
1
7
17
19
-4
3
-4
-2
14
CFO/OP
184
128
93
159
71
160
101
33
136
46
100
182
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
103
95
97
95
97
68
62
78
96
117
94
69
Inventory Days
123
166
145
126
92
75
100
91
96
150
151
228
Days Payable
106
128
123
130
120
97
81
50
98
144
85
111
Cash Conversion Cycle
120
133
119
92
68
46
80
118
93
123
160
186
Working Capital Days
2
8
1
7
78
32
52
99
73
94
92
85
ROCE %
0%
9%
10%
-1%
21%
25%
39%
21%
7%
8%
8%
8%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Smruthi Organics insights

70 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Promot.64.73%Others6.68%Public28.59%As ofSep 2026

Documents

Frequently Asked Questions about Smruthi Organics

What does Smruthi Organics Ltd do?
Incorporated in 1989, Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients[1]
Where is Smruthi Organics Ltd (SMRUTHIORG) listed?
Smruthi Organics Ltd trades under code 540686 on the BSE.
Which sector does Smruthi Organics Ltd belong to?
Smruthi Organics Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Smruthi Organics Ltd?
Smruthi Organics Ltd has a market capitalisation of ₹165.92 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Smruthi Organics Ltd?
Smruthi Organics Ltd trades at a PE ratio of 22.40 as of 29 Oct 2026, on earnings per share of ₹6.47, against a book value of ₹64.22 per share.
What is the 52-week high and low of Smruthi Organics Ltd?
Over the last 52 weeks Smruthi Organics Ltd has traded between ₹95 and ₹175.3 as of 29 Oct 2026.
Does Smruthi Organics Ltd pay dividends?
Smruthi Organics Ltd has a dividend yield of 1.10%.
What is the Return on Equity (ROE) of Smruthi Organics Ltd?
Smruthi Organics Ltd reported a return on equity of 4.66%. Its debt-to-equity ratio is 0.11.

Company Information

Incorporated in 1989, Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients[1]

Website smruthiorganics.com
Listed 2017-08-29
Face Value ₹ 10
Shares Outstanding 1,14,46,921

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540686.md for Smruthi Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month